Your browser doesn't support javascript.
loading
Enzalutamide-induced and PTH1R-mediated TGFBR2 degradation in osteoblasts confers resistance in prostate cancer bone metastases.
Su, Shang; Cao, Jingchen; Meng, Xiangqi; Liu, Ruihua; Vander Ark, Alexandra; Woodford, Erica; Zhang, Reian; Stiver, Isabelle; Zhang, Xiaotun; Madaj, Zachary B; Bowman, Megan J; Wu, Yingying; Xu, H Eric; Chen, Bin; Yu, Haiquan; Li, Xiaohong.
Afiliação
  • Su S; Center for Cancer and Cell Biology, Van Andel Institute, Grand Rapids, MI, 49503, USA.
  • Cao J; Center for Cancer and Cell Biology, Van Andel Institute, Grand Rapids, MI, 49503, USA.
  • Meng X; Center for Cancer and Cell Biology, Van Andel Institute, Grand Rapids, MI, 49503, USA.
  • Liu R; Center for Cancer and Cell Biology, Van Andel Institute, Grand Rapids, MI, 49503, USA; Inner Mongolia University, Hohhot, 010021, China.
  • Vander Ark A; Center for Cancer and Cell Biology, Van Andel Institute, Grand Rapids, MI, 49503, USA.
  • Woodford E; Center for Cancer and Cell Biology, Van Andel Institute, Grand Rapids, MI, 49503, USA.
  • Zhang R; Center for Cancer and Cell Biology, Van Andel Institute, Grand Rapids, MI, 49503, USA; University of Michigan, Ann Arbor, MI, 48109, USA.
  • Stiver I; Center for Cancer and Cell Biology, Van Andel Institute, Grand Rapids, MI, 49503, USA; University of Michigan, Ann Arbor, MI, 48109, USA.
  • Zhang X; Anatomic/Clinical Pathology, Mayo Clinic, Rochester, MN, 55905, USA.
  • Madaj ZB; Bioinformatics & Biostatistics Core, Van Andel Institute, Grand Rapids, MI, 49503, USA.
  • Bowman MJ; Center for Cancer and Cell Biology, Van Andel Institute, Grand Rapids, MI, 49503, USA.
  • Wu Y; Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, MI, 49503, USA.
  • Xu HE; Center for Cancer and Cell Biology, Van Andel Institute, Grand Rapids, MI, 49503, USA.
  • Chen B; Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, MI, 49503, USA.
  • Yu H; Inner Mongolia University, Hohhot, 010021, China.
  • Li X; Center for Cancer and Cell Biology, Van Andel Institute, Grand Rapids, MI, 49503, USA. Electronic address: xiaohong.li@utoledo.edu.
Cancer Lett ; 525: 170-178, 2022 01 28.
Article em En | MEDLINE | ID: mdl-34752846

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Feniltioidantoína / Neoplasias da Próstata / Benzamidas / Neoplasias Ósseas / Receptor Tipo 1 de Hormônio Paratireóideo / Receptor do Fator de Crescimento Transformador beta Tipo II / Nitrilas Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Feniltioidantoína / Neoplasias da Próstata / Benzamidas / Neoplasias Ósseas / Receptor Tipo 1 de Hormônio Paratireóideo / Receptor do Fator de Crescimento Transformador beta Tipo II / Nitrilas Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos